Principal Financial Group Inc. Boosts Stock Position in The Cooper Companies, Inc. $COO

Principal Financial Group Inc. boosted its position in The Cooper Companies, Inc. (NASDAQ:COO) by 5.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 231,151 shares of the medical device company’s stock after purchasing an additional 11,774 shares during the quarter. Principal Financial Group Inc. owned about 0.12% of Cooper Companies worth $16,527,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Root Financial Partners LLC boosted its position in Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after acquiring an additional 162 shares during the last quarter. SJS Investment Consulting Inc. raised its holdings in Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 187 shares during the last quarter. CYBER HORNET ETFs LLC purchased a new position in shares of Cooper Companies during the 2nd quarter worth $36,000. True Wealth Design LLC lifted its stake in shares of Cooper Companies by 484.8% during the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after purchasing an additional 383 shares during the period. Finally, Cromwell Holdings LLC boosted its holdings in shares of Cooper Companies by 128.8% during the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after purchasing an additional 273 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

NASDAQ:COO opened at $70.50 on Thursday. The firm’s fifty day simple moving average is $66.93 and its 200 day simple moving average is $72.28. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The firm has a market capitalization of $13.75 billion, a price-to-earnings ratio of 59.75, a PEG ratio of 1.86 and a beta of 0.84.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a research note on Wednesday, May 27th. Weiss Ratings downgraded shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. Citigroup reissued a “neutral” rating and issued a $76.00 target price (up from $69.00) on shares of Cooper Companies in a research report on Wednesday, July 8th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $81.85.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.